
Oxford Genetics secures funding for DNA cloning system
Venture capital fund manager Mercia Fund Management has invested GBP150,000 in Oxford Genetics. The new biotechnology company is behind SnapFast – a system that simplifies the purchase of synthetic DNA molecules (plasmids). Chief executive of Oxford Genetics, Dr Ryan Cawood, invented the SnapFast system and likens it to